RT Journal Article
T1 Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
A1 O'Gorman, N
A1 Wright, D
A1 Poon, L C
A1 Rolnik, D L
A1 Syngelaki, A
A1 Wright, A
A1 Akolekar, R
A1 Cicero, S
A1 Janga, D
A1 Jani, J
A1 Molina, F S
A1 de Paco Matallana, C
A1 Papantoniou, N
A1 Persico, N
A1 Plasencia, W
A1 Singh, M
A1 Nicolaides, K H
K1 Bayes' theorem
K1 first-trimester screening
K1 mean arterial pressure
K1 placental growth factor
K1 pre-eclampsia
K1 pregnancy-associated plasma protein-A
K1 pyramid of pregnancy care
K1 survival model
K1 uterine artery Doppler
AB To examine the diagnostic accuracy of a previously developed model for prediction of pre-eclampsia (PE) by a combination of maternal factors and biomarkers at 11-13 weeks' gestation. This was a prospective first-trimester multicenter study of screening for PE in 8775 singleton pregnancies. A previously published algorithm was used for the calculation of patient-specific risk of PE in each individual. The detection rates (DRs) and false-positive rates (FPRs) for delivery with PE  In the study population, 239 (2.7%) cases developed PE, of which 17 (0.2%), 59 (0.7%) and 180 (2.1%) developed PE  Assessment of a combination of maternal factors and biomarkers at 11-13 weeks provides effective first-trimester screening for preterm PE. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
YR 2017
FD 2017-05-14
LK http://hdl.handle.net/10668/10757
UL http://hdl.handle.net/10668/10757
LA en
DS RISalud
RD Apr 14, 2025